Epialfa 10mg Injection
Marketer
Metta Life Sciences Private Limited
Salt Composition
Epirubicin (10mg)
Overview Epialfa 10mg Injection
Epialfa 10mg Injection treats various hematologic malignancies and cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it may be used alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial, as incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent; discontinue only under medical guidance. Concomitant use may reduce contraceptive efficacy, necessitating reliable birth control for both partners. Common side effects comprise nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. The drug can cause leukopenia, increasing infection risk, potentially life-threatening. Regular blood tests, monitoring kidney, liver, and heart function, are vital. Prior to treatment, disclose any liver or heart conditions, and all other medications you are taking, as interactions can impact efficacy and drug function. Inform your physician of pregnancy or breastfeeding.
Uses of Epialfa 10mg Injection
Malignancy
Major Benefits of Epialfa 10mg Injection:
Administering this medication will be handled by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Epialfa 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epialfa 10mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Epialfa 10mg Injection works:
The anticancer drug, Epialfa 10mg Injection, targets breast cancer cells by inhibiting topoisomerase II, an enzyme crucial for DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, damages cellular DNA, thus hindering cancer cell proliferation and ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Epialfa 10mg Injection poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Administering Epialfa 10mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use only if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Epialfa 10mg Injection. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be compromised by side effects of Epialfa 10mg Injection. Nausea and vomiting, potential side effects of Epialfa 10mg Injection, can temporarily impair driving skills.
KidneySAFE IF PRESCRIBED
The use of Epialfa 10mg Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification for Epialfa 10mg Injection might be unnecessary in such cases. However, physician consultation is recommended. A reduced dosage may be warranted for patients exhibiting serum creatinine levels exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should use Epialfa 10mg Injection cautiously, potentially requiring dosage modification. Consult a physician before use. Epialfa 10mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Epialfa 10mg Injection :
NA
Facts to Know About Epialfa 10mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Cytotoxic alkaloids |
3,018 People bought this recently